See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Mother's Day
Social Media
Artificial Intelligence
European Union
Vladimir Putin
South America
Donald Trump
Instagram
Infrastructure
Pope Francis
Taxes
Hamas
Published • loading... • Updated

Pliant cuts workforce by 45% following lung trial termination

Summary by Clinical Trials Arena
Pliant is slashing 45% of its workforce in a move to “minimise costs and preserve cash reserves”.The post Pliant cuts workforce by 45% following lung trial termination  appeared first on Clinical Trials Arena.

2 Articles

All
Left
Center
Right
Clinical Trials ArenaClinical Trials Arena

Pliant cuts workforce by 45% following lung trial termination

Pliant is slashing 45% of its workforce in a move to “minimise costs and preserve cash reserves”.The post Pliant cuts workforce by 45% following lung trial termination  appeared first on Clinical Trials Arena.

Read Full Article
biospace.combiospace.com

Pliant Axes 45% of Workforce To Save Cash, Support Late-Stage Clinical Trials

Following challenges with its drug candidate bexotegrast and announcement of a limited-duration stockholder rights program, Pliant is paring back its workforce.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biospace.com broke the news in on Friday, May 2, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal